We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Contact Us

Our Experts

Julie Vose, MD

Julie Vose, MD
  • Neumann M. and Mildred E. Harris Professor and
    Chief of Hematology/Oncology at the University of Nebraska Medical Center
  • 2015-16 President of the American Society of Clinical Oncology (ASCO)
  • Specialist in Non-Hodgkin’s Lymphoma and Hodgkin’s Lymphoma
  • Internationally-recognized researcher and lecturer

Dr. Vose is the Neumann M. and Mildred E. Harris Professor and Chief in the Division of Oncology/Hematology at UNMC which includes 34 physicians specializing in Medical Oncology, Hematology, and Cellular Therapy. Dr. Vose received her medical degree, completed her residency in Internal Medicine, served as Chief Resident, and completed a Fellowship in Hematology/Oncology at UNMC. Dr. Vose also completed a sabbatical at Stanford University. In addition, she completed an MBA in Health Administration through the University of Colorado Business School. She was the 2015-16 President of the American Society of Clinical Oncology (ASCO), the largest international society of healthcare professionals who perform research and treat cancer.

Research Interests:

Novel therapies and translational research in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), and chronic lymphocytic leukemia (CLL) including monoclonal antibodies,immunotherapy, pathway directed agents, stem cell transplantation, and chimeric antigen receptor T-cell (CAR-T) treatments. She has authored over 400 manuscripts on these areas of clinical care and research.

University of Nebraska Medical Center

  • Professor and Chief of Division of Oncology/Hematology
  • Specialist in non-Hodgkin’s lymphoma and Hodgkin’s lymphoma
  • Internationally recognized researcher and lecturer

Our Experts

Tell Your Employer About Cancer Expert Now

If your employer does not offer Cancer Expert Now’s services as an employee benefit, we can contact them and discuss benefits package options without disclosing your identity. Complete the form below, and a Cancer Expert Now representative will contact you to discuss a path forward for Cancer Expert Now to reach out to your employer.

Reach Out
Instagram Linkedin Facebook

Stay up to date with Cancer Expert Now’s emails!

© 2025

Cancer Expert Now, LLC. All Rights Reserved